Macrolane Prospective Survey

NCT01223066 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-08-25

No results posted yet for this study

Summary

The study objective is to evaluate the long term safety when Macrolane Volume Restoration Factor is used in female breasts in clinical practice.

Conditions

  • Females Recently Treated With Macrolane VRF in the Breasts

Sponsors & Collaborators

  • Pharma Consulting Group AB

    collaborator INDUSTRY
  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Per Hedén, Md PhD · Akademikliniken Stockholm

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01223066 on ClinicalTrials.gov